BioDelivery Sciences International Inc Announces Regulatory Approval of ONSOLIS in Taiwan

Monday, 29 Jul 2013 07:10am EDT 

BioDelivery Sciences International, Inc. announced that the regulatory approval of ONSOLIS in Taiwan for the management of cancer pain in opioid tolerant, adult patients with cancer. In Taiwan, BDSI has licensed the commercialization rights to TTY Biopharm, where the product will be marketed under the brand name PAINKYL. 

Company Quote

0.66 +5.50%
24 Dec 2014